vs
STANDARD BIOTOOLS INC.（LAB）与Pathfinder Bancorp, Inc.（PBHC）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Pathfinder Bancorp, Inc.的1.7倍（$19.6M vs $11.8M），Pathfinder Bancorp, Inc.净利率更高（-52.9% vs -177.4%，领先124.5%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -22.6%），Pathfinder Bancorp, Inc.自由现金流更多（$10.4M vs $-23.1M），过去两年Pathfinder Bancorp, Inc.的营收复合增速更高（3.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Pathfinder Bancorp, Inc.是美国区域性银行控股公司，旗下运营探路者银行，服务纽约州中部市场，为个人消费者及中小企业提供存款账户、住房抵押贷款、商业贷款、财富管理等各类金融服务。
LAB vs PBHC — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $11.8M |
| 净利润 | $-34.7M | $-5.6M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -81.1% |
| 净利率 | -177.4% | -52.9% |
| 营收同比 | -11.5% | -22.6% |
| 净利润同比 | -28.8% | -242.4% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $11.8M | ||
| Q3 25 | $19.6M | $13.1M | ||
| Q2 25 | $21.8M | $9.3M | ||
| Q1 25 | $40.8M | $12.6M | ||
| Q4 24 | — | $15.3M | ||
| Q3 24 | $22.1M | $13.4M | ||
| Q2 24 | $22.5M | $10.7M | ||
| Q1 24 | $45.5M | $11.1M |
| Q4 25 | — | $-5.6M | ||
| Q3 25 | $-34.7M | $626.0K | ||
| Q2 25 | $-33.5M | $31.0K | ||
| Q1 25 | $-26.0M | $3.0M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-26.9M | $-4.6M | ||
| Q2 24 | $-45.7M | $2.0M | ||
| Q1 24 | $-32.2M | $2.1M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | -81.1% | ||
| Q3 25 | -168.5% | 5.1% | ||
| Q2 25 | -118.1% | 0.4% | ||
| Q1 25 | -80.8% | 29.5% | ||
| Q4 24 | — | 55.4% | ||
| Q3 24 | -120.9% | -43.1% | ||
| Q2 24 | -134.5% | 23.3% | ||
| Q1 24 | -132.2% | 24.3% |
| Q4 25 | — | -52.9% | ||
| Q3 25 | -177.4% | 4.8% | ||
| Q2 25 | -153.7% | 0.3% | ||
| Q1 25 | -63.8% | 23.6% | ||
| Q4 24 | — | 37.7% | ||
| Q3 24 | -122.0% | -34.6% | ||
| Q2 24 | -203.3% | 18.7% | ||
| Q1 24 | -70.6% | 19.0% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | $0.47 | ||
| Q2 25 | $-0.09 | $0.47 | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | $0.41 | ||
| Q2 24 | $-0.12 | $0.41 | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | $14.1M |
| 股东权益账面价值 | $399.7M | $122.5M |
| 总资产 | $539.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | $14.1M | ||
| Q3 25 | — | $18.7M | ||
| Q2 25 | — | $21.0M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $27.1M | ||
| Q3 24 | $55.2M | $39.8M | ||
| Q2 24 | $55.1M | $45.9M | ||
| Q1 24 | $55.0M | $45.9M |
| Q4 25 | — | $122.5M | ||
| Q3 25 | $399.7M | $126.3M | ||
| Q2 25 | $424.5M | $124.4M | ||
| Q1 25 | $454.6M | $124.9M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | $489.3M | $120.2M | ||
| Q2 24 | $510.3M | $123.3M | ||
| Q1 24 | $577.3M | $121.8M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $539.6M | $1.5B | ||
| Q2 25 | $557.0M | $1.5B | ||
| Q1 25 | $579.6M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $681.5M | $1.5B | ||
| Q2 24 | $708.7M | $1.4B | ||
| Q1 24 | $777.7M | $1.5B |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | 0.11× | 0.33× | ||
| Q2 24 | 0.11× | 0.37× | ||
| Q1 24 | 0.10× | 0.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $10.4M |
| 自由现金流率自由现金流/营收 | -118.1% | 88.1% |
| 资本支出强度资本支出/营收 | 4.5% | 10.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $18.4M |
8季度趋势，按日历期对齐
| Q4 25 | — | $11.7M | ||
| Q3 25 | $-22.2M | $7.0M | ||
| Q2 25 | $-20.7M | $-3.7M | ||
| Q1 25 | $-30.3M | $5.7M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-27.9M | $11.8M | ||
| Q2 24 | $-39.0M | $1.5M | ||
| Q1 24 | $-62.5M | $504.0K |
| Q4 25 | — | $10.4M | ||
| Q3 25 | $-23.1M | $6.9M | ||
| Q2 25 | $-22.6M | $-4.0M | ||
| Q1 25 | $-35.3M | $5.1M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | $-30.1M | $11.3M | ||
| Q2 24 | $-41.0M | $637.0K | ||
| Q1 24 | $-63.3M | $274.0K |
| Q4 25 | — | 88.1% | ||
| Q3 25 | -118.1% | 52.8% | ||
| Q2 25 | -103.6% | -42.6% | ||
| Q1 25 | -86.6% | 40.1% | ||
| Q4 24 | — | 59.9% | ||
| Q3 24 | -136.4% | 84.3% | ||
| Q2 24 | -182.2% | 6.0% | ||
| Q1 24 | -138.9% | 2.5% |
| Q4 25 | — | 10.7% | ||
| Q3 25 | 4.5% | 1.0% | ||
| Q2 25 | 8.7% | 2.4% | ||
| Q1 25 | 12.4% | 5.1% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | 10.2% | 3.8% | ||
| Q2 24 | 8.6% | 8.2% | ||
| Q1 24 | 1.7% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 11.26× | ||
| Q2 25 | — | -120.55× | ||
| Q1 25 | — | 1.92× | ||
| Q4 24 | — | 2.87× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PBHC
| Other | $5.6M | 47% |
| Banking | $3.7M | 31% |
| Deposit Account | $1.5M | 13% |
| Financial Service Other | $1.0M | 9% |
